Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
TB-500 has been through Phase I and Phase II clinical trials of intravenous thymosin beta-4 with no serious adverse events reported in the published cohorts
Levels decline with age, which is one reason researchers are studying exogenous administration as a longevity intervention
Microglia are initially activated to stage 1 DAM, which are characterized by a downregulation of homeostatic microglial genes including p2ry12 and cx3cr1 , and an upregulation of genes including trem2 , tyrobp and apoe
BPC-157 has gained significant attention due to its potential benefits in tissue repair, inflammation reduction, and pain relief
4) Key component in cosmetic formulations for skin health and anti-aging benefits
US$ 22.04
US$ 21.00
US$ 27.69
